Clinical Trials Sponsored by Hellenic Oncology Research Group

Total 384 results

Hellenic Oncology Research Group

Completed

Pemetrexed Plus Bevacizumab in Non Small Cell Lung Cancer

Non-small-cell Lung Cancer

Greece
Hellenic Oncology Research Group

Completed

Nab-Paclitaxel as Salvage Treatment in Locally Advanced or Metastatic Gastric Cancer

Stomach and Gastro-Esophageal Junction (GEJ) Cancer

Greece
Hellenic Oncology Research Group

Terminated

Myocet Plus Endoxan for Older Patients With Breast Cancer

Breast Cancer

Greece
Hellenic Oncology Research Group

Completed

Cabazitaxel in Relapsed and Metastatic NSCLC

NSCLC

Greece
Hellenic Oncology Research Group

Completed

Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer

Breast Cancer

Greece
Hellenic Oncology Research Group

Unknown

Liquid Biopsy as a Tool to Evaluate Resistance to First and Third (AZD9291) (EGFR) (TKIs) in (EGFR) Mutant NSCLC

Non Small Cell Lung Cancer

Greece
Hellenic Oncology Research Group

Completed

Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung Cancer

Non-small-cell Lung Cancer

Greece
Hellenic Oncology Research Group

Completed

Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC

NSCLC

Greece
Hellenic Oncology Research Group

Completed

Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line Treatment

Non Small Cell Lung Cancer

Greece
Hellenic Oncology Research Group

Completed

Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer

Breast Cancer

Greece
Hellenic Oncology Research Group

Unknown

Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment (MINOAS)

Metastatic Colorectal Cancer

Greece
Hellenic Oncology Research Group

Unknown

NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"

Non Small Cell Lung Cancer

Greece
Hellenic Oncology Research Group

Completed

Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer

Ovarian Cancer

Greece
Hellenic Oncology Research Group

Completed

Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Greece
Hellenic Oncology Research Group

Terminated

Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer

Breast Cancer

Greece
Hellenic Oncology Research Group

Terminated

Trial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric Cancer

Gastric Cancer

Greece
Hellenic Oncology Research Group

Completed

Pazopanib in Relapsed and Refractory Small Cell Lung Cancer

SCLC

Greece
Hellenic Oncology Research Group

Completed

Maintenance Bevacizumab or Observation After Taxane Based First Line Chemotherapy In Metastatic Breast Cancer

Metastatic Breast Cancer

Greece
Hellenic Oncology Research Group

Terminated

Docetaxel Plus Bevacizumab for Elderly Patients With Stage IV NSCLC

NSCLC

Greece
Hellenic Oncology Research Group

Completed

Assessment of Clinical Practice Administration of Chemotherapy and Anti-angiogenic Agent (Bevacizumab) in Colorectal Cancer

Metastatic Colorectal Cancer

Greece
Hellenic Cooperative Oncology Group

Recruiting

Durvalumab in Combination With Standard Chemotherapy of Patients With Extensive Stage Small Cell Lung Cancer (DRIVE)

Small-cell Lung Cancer | Extensive-stage Small-cell Lung Cancer

Greece
Hellenic Cooperative Oncology Group

Recruiting

Osimertinib as 1st Line Therapy for Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer

Lung Cancer Non-small Cell Stage IV

Greece
Hellenic Cooperative Oncology Group

Active, not recruiting

Molecular Profiling in Prostate Cancer (ProProstate)

Prostate Cancer Recurrent | Prostate Cancer Metastatic | Mutation | Germline BRCA1 Gene Mutation | Germline BRCA2 Gene Mutation

Greece
Hellenic Cooperative Oncology Group

Completed

Molecular Characterization of Gliomas Using a Broad Next Generation Sequencing (NGS)Panel

Malignant Glioma
Hellenic Cooperative Oncology Group

Active, not recruiting

Melanoma: Genomic Profiles, Molecular Markers and Therapeutic Implications

Melanoma

Greece
Hellenic Cooperative Oncology Group

Completed

Bevacizumab Versus Docetaxel/Erlotinib on Tumor Metrics in Patients With Previously Untreated Advanced Non Small Cell Lung Cancer

Non Small Cell Lung Cancer
Hellenic Cooperative Oncology Group

Terminated

Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma

Kidney Cancer

Greece
Hellenic Cooperative Oncology Group

Terminated

Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse

Ovarian Cancer

Greece
Hellenic Cooperative Oncology Group

Recruiting

Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer

Ovarian Cancer

Greece
Hellenic Cooperative Oncology Group

Active, not recruiting

Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes

Breast Cancer

Greece
Hellenic Cooperative Oncology Group

Completed

Responses to COVID-19 Vaccination in Patients With Cancer (ReCOVer)

Cancer

Greece
Hellenic Cooperative Oncology Group

Completed

Prognostic Biomarkers in Patients With Urothelial Carcinoma

Bladder Cancer
Hellenic Cooperative Oncology Group

Completed

Adjuvant Chemotherapy With Epirubicin, CMF, and Weekly Docetaxel or Weekly Paclitaxel in Patients With Resected High-risk Breast Cancer

Breast Cancer | Adenocarcinoma of Breast
Hellenic Cooperative Oncology Group

Completed

Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease (CIAD)

Autoimmune Diseases | Immunotherapy | Checkpoint Inhibitor

Greece
Hellenic Cooperative Oncology Group

Completed

Germline Mutations in Pancreatic Adenocarcinoma (PaMPA)

Pancreatic Cancer | Hereditary Cancer | Predisposition, Genetic | Germline Mutation Abnormality

Greece
Hellenic Cooperative Oncology Group

Completed

Pathogenic Variants in Homologous Recombination Repair Genes in Patients With Epithelial Ovarian Cancer (PaVaClO)

Epithelial Ovarian Cancer
Hellenic Cooperative Oncology Group

Completed

Real-world Data of Nivolumab in Pre-treated NSCLC

Non Small Cell Lung Cancer
Hellenic Cooperative Oncology Group

Completed

Study of Panitumumab-Capecitabine-Oxaliplatin In Wild-Type K-Ras Metastatic Colorectal Cancer Patients

Colorectal Cancer

Greece
Hellenic Cooperative Oncology Group

Recruiting

Real-world Data in Patients With Breast Cancer Treated With Abemaciclib (HE11AB/21)

Breast Cancer

Greece
Hellenic Cooperative Oncology Group

Recruiting

Molecular Profiling of Colorectal Cancer

Colorectal Cancer | Colon Cancer | Colon Adenocarcinoma

Greece
Hellenic Cooperative Oncology Group

Active, not recruiting

Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer

Ovarian Cancer

Greece
Hellenic Cooperative Oncology Group

Active, not recruiting

Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma

Breast Cancer

Greece
Hellenic Cooperative Oncology Group

Completed

Clinical Outcome and Toxicity Data in Patients With Advanced Breast Cancer Treated With CDK Inhibitors Combined With Endocrine Therapy (HeCOG/CDKi)

Breast Cancer Stage IV

Greece
Hellenic Cooperative Oncology Group

Completed

The Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients With Advanced EGFR Mutation-positive Non-small Cell Lung Cancer Treated With Afatinib

Non Small Cell Lung Cancer | EGF-R Positive Non-Small Cell Lung Cancer | EGFR Gene Mutation
Hellenic Cooperative Oncology Group

Completed

Corellation of Mutations, TILs and Age in Breast Cancer

Breast Cancer
Hellenic Cooperative Oncology Group

Completed

K-RAS and EGFR in Lung Cancer (K-RAS_NSCLC)

Non Small Cell Lung Cancer

Greece
Hellenic Cooperative Oncology Group

Completed

Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors

Breast Tumors | Brain Metastases | Lung Tumors

Greece
Hellenic Cooperative Oncology Group

Terminated

Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT) (HIT)

Metastatic Breast Cancer

Greece
Hellenic Cooperative Oncology Group

Terminated

Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC) (DOPERLO)

Advanced Non-Small Cell Lung Cancer

Greece
Hellenic Cooperative Oncology Group
Hellenic Society of Medical Oncology

Active, not recruiting

Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer

Metastatic Breast Cancer

Greece

3

Subscribe